Stock listing

OTC:VAXX Vaxxinity, Inc. Stock

Follow Vaxxinity, Inc. into a list and get an email when it puts out news.

Share price · OTC:VAXX

$0.0001 USD 0.0000 (0.0%)

Close on Nov 17, 2026

Past year -99.6% · daily closes, Oct 26, 2026 – Nov 17, 2026, adjusted for splits
Day range
$0.0001 – $0.0275 USDNov 17, 2026
Volume
318 sharesNov 17, 2026
Market cap
—Left out: price × shares is far from the company's reported size
Vaxxinity, Inc. logo

Daily closes

Last 3 months, Oct 26, 2026 – Nov 17, 2026 · OTC:VAXX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0275$0.0275$0.0001318
$0.00010.00000.0%$0.0001$0.0205$0.00011,502
$0.0001-0.0009-90.0%$0.0010$0.0010$0.00011,312
$0.00100.00000.0%$0.0010$0.0010$0.0010219
$0.0010-0.0140-93.3%$0.0010$0.0010$0.0010219
$0.0150-0.0100-40.0%$0.0150$0.0150$0.0150230
$0.0250+0.0110+78.6%$0.0250$0.0250$0.0250251
$0.0140-0.0010-6.7%$0.0140$0.0140$0.0140213
$0.01500.00000.0%$0.0150$0.0150$0.0150212
$0.01500.00000.0%$0.0150$0.0150$0.0150212
$0.0150-0.0120-44.4%$0.0150$0.0150$0.0150212
$0.0270+0.0085+45.9%$0.0210$0.0270$0.0210489
$0.0185-0.0090-32.7%$0.0185$0.0185$0.0185215
$0.0275——$0.0275$0.0275$0.0275215
Ticker
OTC:VAXX
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

All Vaxxinity, Inc. news

Vaxxinity, Inc. on 6ix

News releases
7 in all · newest Dec 12, 2023 · oldest 2023

Valuation

price Nov 17, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.73

Team and board

OfficerRole
Mei Mei HuChief Executive Officer

Events

QuarterResults
Quarter to Sep 30, 2025Nov 28, 2025
Quarter to Jun 30, 2025Aug 29, 2025
Quarter to Mar 31, 2025Apr 1, 2025
Quarter to Sep 30, 2024Nov 29, 2024
Quarter to Jun 30, 2024Aug 8, 2024
Q1 2024May 7, 2024
Q4 2023Mar 27, 2024 · After close
Q3 2023Nov 8, 2023 · Before open
Q2 2023Aug 9, 2023 · Before open
Q1 2023May 9, 2023 · Before open
All 19 quarters
QuarterResults
Q4 2022Mar 27, 2023 · Before open
Q3 2022Nov 10, 2022 · Before open
Q2 2022Aug 11, 2022 · Before open
Q1 2022May 9, 2022 · Before open
Q4 2021Mar 24, 2022 · After close
Q3 2021Dec 23, 2021 · After close
Q2 2021Sep 30, 2021
Q1 2021Jun 30, 2021
Q4 2020Mar 31, 2021

Open Events

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019
Revenue0-1.00K66.0K557.0K0
Cost of revenue2.23M1.68M1.94M52.0K107.0K
Gross profit-2.23M-1.68M-1.87M505.0K-107.0K
Research and development33.7M47.6M71.4M20.6M10.7M
Selling, general and administrative22.4M28.4M51.8M12.2M3.00M
Operating income-58.3M-76.0M-125.1M-32.3M-13.7M
Depreciation and amortization2.23M1.68M1.10M717.0K107.0K
EBITDA-56.1M-74.3M-124.0M-31.6M-13.6M
Interest expense696.0K514.0K840.0K1.18M435.0K
Income before tax-56.9K-75.2M-137.2M-40.0M-14.2M
Income tax-56.9K-12.0K840.0K-4.58M56.0K
Net income-56.9K-75.2M-137.2M-40.0M-14.2M
Earnings per share, basic-0.00-0.60-1.09-0.32-0.11

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019
Cash and equivalents4.93M33.5M144.9M31.1M476.0K
Short-term investments25.5M53.4M869.0K10.0K
Receivables414.0K414.0K393.0K387.0K303.0K
Inventory6.12M8.51M3.31M
Current assets33.2M93.9M154.1M35.7M1.44M
Property, plant and equipment12.5M12.2M12.2M160.0K
Total assets44.3M106.4M166.7M50.1M1.59M
Accounts payable1.78M5.29M3.19M9.02M1.28M
Current liabilities17.6M30.9M27.5M37.2M19.9M
Long-term debt13.3M9.93M10.3M10.7M1.12M
Total debt15.2M14.5M10.7M38.3M14.3M
Total liabilities30.9M44.2M38.1M137.5M50.1M
Shareholders' equity13.4M62.2M128.6M-87.4M-48.5M
Shares outstanding126.5M125.9M125.4M125.5M125.5M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019
Cash from operations-57.2M-55.9M-81.0M-33.9M-12.3M
Capital spending-803.0K-1.87M-1.32M-1.48M-1.48M
Free cash flow-58.0M-57.8M-82.3M-35.4M-12.3M
Cash from investing28.8M-54.4M-1.32M-1.48M-1.48M
Cash from financing-1.14M-167.0K196.2M66.1M11.1M
Dividends paid-59.8M
Share buybacks263.0K59.9M-41.0K0
Change in cash-29.5M-110.5M113.9M30.7M-1.13M

Open Financials

Cap table

Built by 6ix from Vaxxinity, Inc.’s releases

Common shares
112,910,552
Fully diluted
112,910,552

Fully diluted

LineShares
Common shares112,910,552

Share count over time

CountShares
Nov 22, 2026112,910,552

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Peter Diamandis
Other companies: Celularity Inc. (Director · Since at least Jul 16, 2021); DPCM Capital Inc (Director · Oct 20, 2020 – Aug 5, 2022 · Past); CuriosityStream Inc. (Director · Nov 19, 2019 – Nov 19, 2019 · Past)
Director · Nov 10, 2021 – Jun 20, 2023 · Past
Farshad Guirakhoo
Other companies: GeoVax Labs, Inc. (Chief Scientific Officer · Oct 19, 2015 – Dec 17, 2018 · Past)
Chief Scientific Officer · Nov 10, 2021 – May 3, 2022 · Past
George R Hornig
Other companies: Healthwell Acquisition Corp I (Director · Aug 2, 2021 – Aug 2, 2021 · Past)
Director · Jan 3, 2022 – Jun 20, 2023 · Past
Katherine A Eade
Other companies: Harvard Bioscience, Inc. (Director · Since at least Oct 24, 2017)
Director · Feb 1, 2023 – Jun 20, 2023 · Past
James Alan SmithDirector · Feb 1, 2023 – Jun 20, 2023 · Past
Jason PesileSee Remarks · Jan 3, 2022 – Mar 7, 2023 · Past
Landon E OgilvieDirector · Feb 1, 2023 – Jun 20, 2023 · Past
Lou ReeseSee Remarks, Director · Nov 10, 2021 – Mar 7, 2023 · Past
Martin DoranSee Remarks · Nov 10, 2021 – Nov 10, 2021 · Past
Mei Mei HuChief Executive Officer · Since at least Nov 5, 2026
All 12 people
PersonSeat
Peter PowchikDirector · Mar 31, 2022 – Oct 1, 2023 · Past
Ulo PalmSee Remarks · Nov 10, 2021 – Mar 7, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Vaxxinity, Inc.